Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Original Article
Review Article

The American Journal of Ophthalmic Clinical Trials is an open-access peer-reviewed international journal committed to publishing high-quality articles in the field of Ophthalmology. The journal aims to present the most current information in Ophthalmology by summarizing recent clinical trials in light of practice patterns and previous studies. The journal is owned and published by the Scientific Scholar.


Our audience includes Ophthalmologists, Optometrists, Researchers, Clinicians, other medical professionals, and medical students. The goal is to create meaningful summaries on how clinical studies impact the clinical care of patients.

Review Process

AJOCT has a highly rigorous double-blinded peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts of interest, affiliations and financial disclosures such that the published content is not biased.

In-house submissions that contain the work of any editorial board member, are not allowed to be reviewed by that editorial board member and all decisions regarding this manuscript are made by an independent editor. In addition, these manuscripts are reviewed by two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.

Editorial Team

The editorial board comprises a panel of experts in ophthalmology considered leaders from various countries to provide their expertise and guidance to the Editor-In-Chief in maintaining the clarity of content and focus of the journal’s purpose.

About the Editor

Rishi P. Singh, MD
Editor-in-Chief, American Journal of Ophthalmic Clinical Trials

Dr. Rishi P. Singh, MD is a staff surgeon at the Cole Eye Institute, Cleveland Clinic and Associate Professor of Ophthalmology at the Lerner College of Medicine in Cleveland Ohio. He also currently serves as the medical director of informatics at the Cleveland Clinic. He received his bachelors and medical degrees from Boston University and completed his residency at the Massachusetts Eye and Infirmary Harvard Combined Program in Boston, Massachusetts. Dr. Singh then completed a medical and surgical fellowship at the Cole Eye Institute in Cleveland, Ohio.

He specializes in the treatment of medical and surgical retinal diseases such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored greater than 110 peer-reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. He is frequently invited to speak at national and international meetings, as well as continuing medical education seminars. Dr. Singh is also a reviewer for various ophthalmology and medical publications including Archives of Ophthalmology, American Journal of Ophthalmology, IOVS, and Ophthalmology. He maintains a strong relationship with drug development and commercial entities by serving on scientific advisory boards. Dr. Singh is the current president on the Retina World Congress and is on the board of the American Society of Retina Specialists.

Dr. Singh’s current work focuses on electronic medical records implementation, lean process improvement, and decision support modules for clinical practice. He operates the Cleveland Clinic Electronic Health Record Consulting program. Dr. Singh has been honored with several research recognitions such as the Alpha Omega Alpha Research Award and the American Society of Retina Specialists Senior Honor Award.

Facts About the Journal

Scope of American Journal of Ophthalmic Clinical Trials
The AJOCT will cover technical and clinical studies related to health, ethical and social issues in the field of ophthalmology. Manuscripts with high clinical interest and implications will be given preference.

The mission of this journal is to publish, promote, educate, and spread the knowledge of ophthalmology in a manner that enables Ophthalmologists to clearly comprehend concepts and practices and encourage further research and technical innovations.

American Journal of Ophthalmic Clinical Trials is a platform for practicing Ophthalmologists, researchers, and students to share, learn, and gain an in-depth understanding of the concepts and practices of Ophthalmology, and to understand the technical advancements within the field. The journal aims to make available cutting-edge technical and relevant knowledge to Ophthalmologists leading to optimal healthcare for all. It intends to maintain the highest standard of professionalism to ensure the advancement of Ophthalmology to the next level.

American Journal of Ophthalmic Clinical Trials will have eight categories covering all sub-specialties of ophthalmology: Comprehensive, Cornea, Glaucoma, Refractive, Plastics, Retina, Uveitis, and Neuro-ophthalmology. The journal publishes original research papers, papers on technical innovations, review articles, innovations, pictorial essays, case reports, case series and letters to editors. The journal allows free access to its articles.

Many journals consider case reports to have a low impact factor. If done correctly, case reports can be the basic building blocks of medical knowledge in Ophthalmology. We strongly encourage authors to send case reports for publication in our journal. We believe case reports stimulate the reader’s thought processes and encourage them to think of novel and varied paths. This, in turn, results in the generation of new research ideas and is very important in promoting scientific investigation and exploration.

It is a peer-reviewed international journal with a double-blind review process. Its frequency of publication is continuous, what that means is, it publishes the article once it’s accepted after peer review. Currently, we only have E-Journal and do not publish in print.


A manuscript published in the AJOCT can be read and downloaded by readers all over the world without any charges or fees. The author retains the copyright of the manuscript and the figures. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work.

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:

Google Scholar, CrossRef, ReadCube, Index Copernicus, Scilit, China National Knowledge Infrastructure (CNKI), Wang Fung

Journal Ethics

The American Journal of Ophthalmic Clinical Trials is committed to meeting and upholding ethical guidelines at all stages of the publication process. We follow the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines section.

Plagiarism Policy

We provide plagiarism check software (iThenticate) on the Editor’s and Reviewer’s panel in the manuscript management system. We encourage our editors and reviewers to use the plagiarism check. The manuscript’s found to have plagiarism is rejected.

Archival Policy

We use PORTICO for our third-party repository for all articles published with us. All our manuscripts are assigned a DOI number from CROSSREF, and we are members of Crossref

Open Access Publication and Creative Commons Licensing

American Journal of Ophthalmic Clinical Trials is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Ahead of Print Policy

AJOCT is a continuous publication.

Subscription Information

AJOCT  is a continuous publication and published manuscripts in the journal can be read and downloaded by readers all over the world without any charges or fees.

AJOCT is published in E-Journal format and the journal is also available in print on demand. The journal offers a Print-on-Demand subscription –


Imaging Science Today was founded in 2011 by a group of practicing doctors and industry specialists, it changed its name to Scientific Scholar LLC, USA ( All the scientific journal publishing of Imaging Science Today was brought under the umbrella of Scientific Scholar LLC in 2017. Scientific Scholar LLC ( is a well-respected medical publisher that fully supports open access publishing models, Subscription and Society based journal models through its peer-review management system – EditorialAssist ( The head office of Scientific Scholar (  is in Rochester, NY, USA and has a subsidiary arm in India.

Scientific Scholar (  owns its Manuscript Management System called EditorialAssist ( This system is very intuitive with a very short learning curve. The overall functionality of this system is based on “DRAG AND DROP”.

The mission of the Scientific Scholar ( is “Share, Learn and Improve”.

Scientific Scholar (  currently publishes many prestigious and indexed journals like the Journal of Clinical Imaging Science (,  Surgical Neurology International (,  CytoJournal ( and many more ( Scientific Scholar ( currently publishes approximately thirty three peer-reviewed journals.